284 filings
Page 2 of 15
8-K
eepbtp zjji
11 May 23
SELLAS Life Sciences Provides Business Update and Reports First Quarter 2023 Financial Results
4:16pm
8-K
hd3w3q
16 Mar 23
SELLAS Life Sciences Reports Full Year 2022 Financial Results and Provides Business Update
4:13pm
8-K
tns7ua8 27wlyporu
10 Mar 23
Regulation FD Disclosure
4:11pm
8-K
l0zsrj9p ztwqp
1 Mar 23
Entry into a Material Definitive Agreement
7:45am
8-K
bmr8qrcf1pas2v4n21xz
24 Feb 23
Entry into a Material Definitive Agreement
8:39am
8-K
k6iib5cg7boem o4
23 Feb 23
Results of Operations and Financial Condition
4:05pm
8-K
d0rb0
6 Feb 23
Departure of Directors or Certain Officers
4:20pm
8-K
rl0halcbltdldzy8mx
13 Dec 22
SELLAS Announces Positive Phase 1 Data with CDK9 Inhibitor
8:38am
8-K
06csi
15 Nov 22
Regulation FD Disclosure
4:15pm
8-K
i7915iciwzyc1 kc3c
14 Nov 22
SELLAS Life Sciences Provides Business Update and Reports Third Quarter 2022 Financial Results
8:17am
8-K
oxf73r5rcl24k
16 Sep 22
Regulation FD Disclosure
5:05pm
8-K
i5sbk4idza
16 Aug 22
SELLAS Life Sciences’ Announces Election of Katherine Bach Kalin
4:05pm
8-K
zt2v0ko4xo8qx
11 Aug 22
SELLAS Life Sciences Provides Business Update and Reports Second Quarter 2022 Financial Results
4:14pm
8-K
vrxkm
9 Jun 22
Submission of Matters to a Vote of Security Holders
4:12pm
8-K
y38k8nmw y0gjid
12 May 22
SELLAS Life Sciences Reports First Quarter 2022 Financial Results and Provides Business Update
4:16pm
8-K
ostdbdytix10jm 2pm
6 Apr 22
Regulation FD Disclosure
5:01pm
8-K
aucsdla8362tzzym xk
1 Apr 22
Entry into a Material Definitive Agreement
4:54pm
8-K
hwbnzkoj9kjs727tsyu
31 Mar 22
Entry into a Material Definitive Agreement
12:00am
8-K
702 d5j2lp
16 Dec 21
Departure of Directors or Certain Officers
4:14pm
8-K
d8gq1
12 Nov 21
SELLAS Life Sciences Reports Third Quarter 2021 Financial Results and Provides Business Update
8:49am